Accelerating the introduction of rotavirus immunization in Indonesia

Auliya A. Suwantika, Neily Zakiyah, Keri Lestari, Maarten J. Postma*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

11 Citations (Scopus)


The introduction of the rotavirus vaccine in Indonesia is currently in its infancy. Delay in its development might be caused by factors related to the perceived value of the vaccine, health system characteristics and policy considerations. Other factors, which may also interfere with optimizing the introduction, are financial barriers because Indonesia is a lower-middle-income country. Creating fiscal space to finance new immunization programs, such as for the rotavirus immunization, is very important to ensure the sustainability of new programs so that such programs would be financed over the long term and not endanger the sustainability of the Indonesian government's financial position. This article provides an illustration of the various steps needed to accelerate the introduction of the rotavirus immunization.

Original languageEnglish
Pages (from-to)463-472
Number of pages10
JournalExpert review of vaccines
Issue number4
Publication statusPublished - Apr-2014


  • Vaccine
  • Rotavirus vaccine
  • cost effectiveness analysis
  • drug cost
  • health care policy
  • health care system
  • human
  • immunization
  • Indonesia
  • lowest income group
  • priority journal
  • review
  • Rotavirus infection
  • virus transmission

Cite this